These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 609604)

  • 41. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
    Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
    Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonists.
    Jones DG; Liang X; Stewart EL; Noe RA; Kallander LS; Madauss KP; Williams SP; Thompson SK; Gray DW; Hoekstra WJ
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3203-6. PubMed ID: 15925510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives.
    Chimenti F; Bizzarri B; Manna F; Bolasco A; Secci D; Chimenti P; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
    Bioorg Med Chem Lett; 2005 Feb; 15(3):603-7. PubMed ID: 15664821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polysubstituted pyrazoles. 1. Synthesis of 4-(4-substituted substituted sulphonamidophenylhydrazono)-2-pyrazolin-5-ones of anticipated hypoglycemic activity.
    Shafik RM; Soliman FS
    Pharmazie; 1974 Apr; 29(4):290-1. PubMed ID: 4853694
    [No Abstract]   [Full Text] [Related]  

  • 45. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.
    Ucar G; Gokhan N; Yesilada A; Bilgin AA
    Neurosci Lett; 2005 Jul; 382(3):327-31. PubMed ID: 15925113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polysubstituted pyrazoles. Part 2: Sulphonamidophenylhydrazone-2-pyrazolin-4-ones and sulphonamidophenylazopyrazoles as potential anticancer agents.
    Soliman FS; Shafik RM
    Pharmazie; 1975 Jul; 30(7):436-9. PubMed ID: 1178757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bis-pyrazolines: synthesis, characterization and antiamoebic activity as inhibitors of growth of Entamoeba histolytica.
    Bhat AR; Athar F; Azam A
    Eur J Med Chem; 2009 Jan; 44(1):426-31. PubMed ID: 18187238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives.
    Budakoti A; Abid M; Azam A
    Eur J Med Chem; 2007 Apr; 42(4):544-51. PubMed ID: 17156895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Energy-variable collision-induced dissociation study of 1,3,5-trisubstituted 2-pyrazolines by electrospray mass spectrometry.
    Kéki S; Nagy L; Török J; Tóth K; Lévai A; Zsuga M
    Rapid Commun Mass Spectrom; 2007; 21(11):1799-808. PubMed ID: 17486690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
    Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
    Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel indolyl pyrazolines as monoamine oxidase inhibitors.
    Tripathi S; Pandey BR; Barthwal JP; Kishore K; Bhargava KP
    Indian J Physiol Pharmacol; 1980; 24(2):155-9. PubMed ID: 7380531
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel bis(1-acyl-2-pyrazolines) of potential anti-inflammatory and molluscicidal properties.
    Barsoum FF; Hosni HM; Girgis AS
    Bioorg Med Chem; 2006 Jun; 14(11):3929-37. PubMed ID: 16460945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyridines and pyrazolines from salicylic acid derivatives with propenone residue and their antimicrobial properties.
    Grant N; Mishriky N; Asaad FM; Fawzy NG
    Pharmazie; 1998 Aug; 53(8):543-7. PubMed ID: 9741063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines.
    Bilgin AA; Palaska E; Sunal R
    Arzneimittelforschung; 1993 Oct; 43(10):1041-4. PubMed ID: 8267665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential antineoplastics--1-substituted thiocarbamoyl-3,5-disubstituted pyrazoles.
    Mokhtar HM; Faid-Allah HM
    Pharmazie; 1987 Jul; 42(7):481. PubMed ID: 3671476
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficient synthesis of 2,3-dihydro-1H-pyrazoles via a highly selective Pd(0)-catalyzed coupling-cyclization reaction of terminal 2-substituted 2,3-allenyl hydrazines with aryl iodides.
    Cheng X; Ma S
    Chem Commun (Camb); 2009 Jul; (28):4263-5. PubMed ID: 19585041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preparation of 3,5-diaminopyrazoles. 3. Synthesis of 1,3-dithietanes].
    Peseke K
    Pharmazie; 1976 Aug; 31(8):532-4. PubMed ID: 996070
    [No Abstract]   [Full Text] [Related]  

  • 58. [The preparation of a 3-alkylindazoles].
    Hannig E; Kollmorgen C; Körner M
    Pharmazie; 1976 Aug; 31(8):534-6. PubMed ID: 996071
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis of fully substituted pyrazoles via regio- and chemoselective metalations.
    Despotopoulou C; Klier L; Knochel P
    Org Lett; 2009 Aug; 11(15):3326-9. PubMed ID: 19580307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diaryl substituted pyrazoles as potent CCR2 receptor antagonists.
    Pinkerton AB; Huang D; Cube RV; Hutchinson JH; Struthers M; Ayala JM; Vicario PP; Patel SR; Wisniewski T; DeMartino JA; Vernier JM
    Bioorg Med Chem Lett; 2007 Feb; 17(3):807-13. PubMed ID: 17088058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.